{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:19:48Z","timestamp":1782857988635,"version":"3.54.5"},"reference-count":256,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018944","name":"Grupo Ferrer Internacional SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.arteri.2025.500889","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:16:19Z","timestamp":1770034579000},"page":"500889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Est\u00e1ndares SEA 2026 para el control global del riesgo vascular"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-6051","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"Mostaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Armario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Guijarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Masana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 T.","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Arrobas-Velilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Baeza-Trinidad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Calmarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Cebollada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Civera-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 I.","family":"Cuende Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"D\u00edaz-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinto","family":"Fern\u00e1ndez Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Jeric\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lahoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"L\u00f3pez-Melgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"L\u00f3pez-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mart\u00ednez-Herv\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidio","family":"Mu\u00f1iz-Grijalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"P\u00e1ramo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pedro-Botet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"P\u00e9rez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Puzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Tamarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2025.500889_bib1000","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1157\/13099239","article-title":"[Value of the ankle-brachial index in cardiovascular risk stratification of patients without known atherotrombotic disease. MERITO study]","volume":"128","author":"Manzano","year":"2007","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.arteri.2025.500889_bib1005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0210-4806(07)73607-0","article-title":"[Development and psychometric validation of a new screening questionnaire for erectile dysfunction (SQUED questionnaire)]","volume":"31","author":"Mart\u00edn-Morales","year":"2007","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.arteri.2025.500889_bib1010","first-page":"3","article-title":"Validez del \u201cFagerstr\u00f6m Tolerance Questionnaire\u201d como medida de dependencia f\u00edsica de la nicotina: una revisi\u00f3n","volume":"19","author":"Carrasco Gim\u00e9nez","year":"1994","journal-title":"Rev Esp Drogodep."},{"key":"10.1016\/j.arteri.2025.500889_bib1015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archinte.1993.00410010062005","article-title":"Cigarette smoking, nicotine addiction, and its pharmacologic treatment","volume":"153","author":"Lee","year":"1993","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1020","unstructured":"Junta de Andaluc\u00eda. Cuestionario de Adherencia a la Dieta Mediterr\u00e1nea (MEDAS) [consultado 19 Dic 2025]. Disponible en: https:\/\/www.juntadeandalucia.es\/export\/drupaljda\/salud_5af95872a79e2_adherencia_dieta_mediterranea.pdf."},{"key":"10.1016\/j.arteri.2025.500889_bib1025","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc."},{"key":"10.1016\/j.arteri.2025.500889_bib1030","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens."},{"key":"10.1016\/j.arteri.2025.500889_bib1035","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1040","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jacc.2025.05.007","volume":"86","author":"Jones","year":"2025","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1045","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/HJH.0000000000002843","article-title":"2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement","volume":"39","author":"Stergiou","year":"2021","journal-title":"J Hypertens."},{"key":"10.1016\/j.arteri.2025.500889_bib1050","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1365-2796.2004.01316.x","article-title":"Coronary heart disease in a patient with cerebrotendinous xanthomatosis","volume":"255","author":"Valdivielso","year":"2004","journal-title":"J Intern Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1055","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1515\/cclm-2019-1253","article-title":"Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM","volume":"58","author":"Langlois","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1060","first-page":"91","article-title":"Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?","volume":"35","author":"Arrobas Velilla","year":"2023","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1065","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1070","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120479","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","author":"Mach","year":"2025","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib1075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11883-014-0440-2","article-title":"Hyperlipoproteinemia type 3: the forgotten phenotype","volume":"16","author":"Hopkins","year":"2014","journal-title":"Curr Atheroscler Rep."},{"key":"10.1016\/j.arteri.2025.500889_bib1080","first-page":"243","article-title":"Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice","volume":"36","author":"Delgado-Lista","year":"2024","journal-title":"Clin Investig Arterioscler."},{"issue":"4S","key":"10.1016\/j.arteri.2025.500889_bib1085","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"key":"10.1016\/j.arteri.2025.500889_bib1090","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/ckj\/sfac019","article-title":"The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: adding albuminuria to the SCORE scale increases the prevalence of very high\/high cardiovascular risk among patients with chronic kidney disease","volume":"15","author":"Cebri\u00e1n","year":"2022","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.arteri.2025.500889_bib1095","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","article-title":"Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract","volume":"39","author":"Mach","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"290","year":"2019","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib1105","first-page":"219","article-title":"Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale\u00ae)","volume":"32","author":"Pint\u00f3","year":"2020","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1210\/clinem\/dgac503","article-title":"Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease","volume":"108","author":"Paquette","year":"2022","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.arteri.2025.500889_bib1115","first-page":"170","article-title":"Lipid and lipoprotein parameters for detection of familial hypercholesterolemia in childhood. The DECOPIN Project","volume":"30","author":"Plana","year":"2018","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1125","first-page":"80","volume":"27","author":"Ascaso","year":"2015","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.arteri.2025.500889_bib1135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacl.2020.04.011","article-title":"Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association","volume":"14","author":"Brown","year":"2020","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2025.500889_bib1140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2021.10.015","article-title":"Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia","volume":"340","author":"Tromp","year":"2022","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib1145","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/ehjci\/jeaa201","volume":"21","author":"Dweck","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.arteri.2025.500889_bib1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101287","article-title":"Coronary Artery Calcium Staging to Guide Preventive Interventions: A Proposal and Call to Action","volume":"3","author":"Maron","year":"2024","journal-title":"JACC Adv."},{"key":"10.1016\/j.arteri.2025.500889_bib1155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacl.2020.12.005","article-title":"The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction","volume":"15","author":"Orringer","year":"2021","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2025.500889_bib1160","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1165","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary Calcium Score and Cardiovascular Risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100664","article-title":"Coronary Artery Calcium Score as a Graded Decision Tool","volume":"2","author":"Gaine","year":"2023","journal-title":"JACC Adv."},{"key":"10.1016\/j.arteri.2025.500889_bib1175","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.120.050545","article-title":"Very High Coronary Artery Calcium (\u22651000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA","volume":"143","author":"Peng","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcmg.2019.02.005","article-title":"Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC \u22651,000: Results From the CAC Consortium","volume":"13","author":"Peng","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.arteri.2025.500889_bib1185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jcmg.2024.12.008","article-title":"Guideline-Directed Application of Coronary Artery Calcium Scores for Primary Prevention of Atherosclerotic Cardiovascular Disease","volume":"18","author":"Pavlovi\u0107","year":"2025","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.arteri.2025.500889_bib1190","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2021.08.019","article-title":"Modeling the Recommended Age for Initiating Coronary Artery Calcium Testing Among At-Risk Young Adults","volume":"78","author":"Dzaye","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1195","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rx.2009.09.009","article-title":"[Coronary artery calcium quantification with non-ECG-gated low-radiation dose CT of the chest]","volume":"52","author":"Bastarrika","year":"2010","journal-title":"Radiologia."},{"key":"10.1016\/j.arteri.2025.500889_bib1200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcct.2016.11.003","article-title":"2016 SCCT\/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology","volume":"11","author":"Hecht","year":"2017","journal-title":"J Cardiovasc Comput Tomogr."},{"key":"10.1016\/j.arteri.2025.500889_bib1205","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1210","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/eurheartj\/ehae190","article-title":"Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography","volume":"45","author":"Nurmohamed","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/eurheartj\/ehae742","article-title":"Clinical risk prediction, coronary computed tomography angiography, and cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials","volume":"46","author":"Rasmussen","year":"2025","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcmg.2023.05.020","article-title":"AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD","volume":"17","author":"Nurmohamed","year":"2024","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.arteri.2025.500889_bib1225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2018.10.066","article-title":"Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study","volume":"73","author":"Williams","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1230","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1235","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcct.2022.07.002","volume":"16","author":"Cury","year":"2022","journal-title":"J Cardiovasc Comput Tomogr."},{"key":"10.1016\/j.arteri.2025.500889_bib1240","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jama.2012.9630","article-title":"Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis","volume":"308","author":"Den Ruijter","year":"2012","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2025.500889_bib1245","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc Dis."},{"key":"10.1016\/j.arteri.2025.500889_bib1250","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ejvs.2015.06.115","article-title":"Long-term Mortality in Patients with Asymptomatic Carotid Stenosis: Implications for Statin Therapy","volume":"50","author":"Giannopoulos","year":"2015","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"10.1016\/j.arteri.2025.500889_bib1255","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jacc.2024.06.045","article-title":"Influence of Subclinical Atherosclerosis Burden and Progression on Mortality","volume":"84","author":"Fuster","year":"2024","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1260","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jacc.2016.05.084","article-title":"A Simple Disease-Guided Approach to Personalize ACC\/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study","volume":"68","author":"Mortensen","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1265","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jacc.2015.01.017","article-title":"Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study","volume":"65","author":"Baber","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.14740\/cr1318","article-title":"Effect of Statin Treatment in Patients With Advanced Carotid Atherosclerosis: An Observational Outcome Study","volume":"12","author":"Adams","year":"2021","journal-title":"Cardiol Res."},{"key":"10.1016\/j.arteri.2025.500889_bib1275","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.echo.2020.04.021","article-title":"Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography","volume":"33","author":"Johri","year":"2020","journal-title":"J Am Soc Echocardiogr."},{"key":"10.1016\/j.arteri.2025.500889_bib1280","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.echo.2021.12.016","article-title":"Reliability, Reproducibility, and Advantages of Measuring Carotid Total Plaque Area","volume":"35","author":"Azarpazhooh","year":"2022","journal-title":"J Am Soc Echocardiogr."},{"key":"10.1016\/j.arteri.2025.500889_bib1285","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.114.014310","article-title":"Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study","volume":"131","author":"Fern\u00e1ndez-Friera","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1290","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jacc.2017.05.033","article-title":"Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study","volume":"70","author":"L\u00f3pez-Melgar","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0021-9150(00)00665-1","article-title":"Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1))","volume":"156","author":"Belcaro","year":"2001","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib1300","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1305","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes","year":"2008","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2025.500889_bib1315","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1320","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1325","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3945\/jn.110.135566","article-title":"A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women","volume":"141","author":"Schr\u00f6der","year":"2011","journal-title":"J Nutr."},{"key":"10.1016\/j.arteri.2025.500889_bib1330","first-page":"25","article-title":"La complejidad cl\u00ednica de las hipertrigliceridemias severas y las unidades de l\u00edpidos [The clinical complexity of severe hypertriglyceridemia and lipids units]","volume":"25","author":"Pint\u00f3","year":"2013","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1335","unstructured":"Junta de Andaluc\u00eda. Cuestionario Internacional de Actividad F\u00edsica (IPAQ) [consultado 19 Dic 2025]. Disponible en: https:\/\/www.juntadeandalucia.es\/export\/drupaljda\/salud_5af95872aeaa7_cuestionario_actividad_fisica_ipaq.pdf."},{"key":"10.1016\/j.arteri.2025.500889_bib1340","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1258\/0004563021901757","article-title":"Limited clinical utility of high-sensitivity plasma C-reactive protein assays","volume":"39","author":"Campbell","year":"2002","journal-title":"Ann Clin Biochem."},{"key":"10.1016\/j.arteri.2025.500889_bib1345","doi-asserted-by":"crossref","first-page":"3478a","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1350","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J."},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2025.500889_bib1355","first-page":"S1","article-title":"Introduction: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arteri.2025.500889_bib1360","unstructured":"World Health Organization. BMI Classification [consultado 19 Dic 2025]. Disponible en: http:\/\/apps.who.int\/bmi\/index.jsp?introPage=intro_3.htmlhttps:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/body-mass-index"},{"key":"10.1016\/j.arteri.2025.500889_bib1365","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1370","unstructured":"National Health Interview Survey. Centre for Disease Control and Prevention (CDC) [consultado 19 Dic 2025]. Disponible en: https:\/\/www.cdc.gov\/nchs\/nhis\/index.html"},{"key":"10.1016\/j.arteri.2025.500889_bib1375","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl."},{"key":"10.1016\/j.arteri.2025.500889_bib1380","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2025.500889_bib1385","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1390","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","year":"2021","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1395","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/eurheartj\/ehad260","article-title":"SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe","volume":"44","year":"2023","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1400","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019589","article-title":"Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC\/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts","volume":"10","author":"Akintoye","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.arteri.2025.500889_bib1405","article-title":"Vascular age calculation from SCORE2 and SCORE2-OP cardiovascular risk tables","author":"Cuende","year":"2025","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1410","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.recesp.2017.01.031","article-title":"Vascular Age, RR, ALLY, RALLY and Vascular Speed, Based on SCORE: Relations Between New Concepts of Cardiovascular Prevention","volume":"71","author":"Cuende","year":"2018","journal-title":"Rev Esp Cardiol (Engl Ed)."},{"key":"10.1016\/j.arteri.2025.500889_bib1415","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study)","volume":"135","author":"P\u00e9rez de Isla","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1420","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2019.02.003","article-title":"Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia","volume":"284","author":"P\u00e9rez-Calahorra","year":"2019","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib1425","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2019.10.016","article-title":"Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype","volume":"292","author":"Ramos","year":"2020","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib1430","article-title":"Recommendations of the Spanish Arteriosclerosis Society: The diet in cardiovascular prevention - 2024 Update","volume":"37","author":"Ros","year":"2025","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1435","first-page":"280","article-title":"Document of recommendations of the SEA 2018. Lifestyle in cardiovascular prevention","volume":"30","author":"P\u00e9rez-Jim\u00e9nez","year":"2018","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1440","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"PREDIMED Study Investigators. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1445","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.numecd.2009.12.007","article-title":"Olive oil and health: summary of the II international conference on olive oil and health consensus report, Ja\u00e9n and C\u00f3rdoba (Spain) 2008","volume":"20","author":"L\u00f3pez-Miranda","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"10.1016\/j.arteri.2025.500889_bib1450","doi-asserted-by":"crossref","first-page":"330S","DOI":"10.3945\/an.113.005389","article-title":"Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study","volume":"5","author":"Ros","year":"2014","journal-title":"Adv Nutr."},{"key":"10.1016\/j.arteri.2025.500889_bib1455","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial","volume":"399","author":"Delgado-Lista","year":"2022","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500889_bib1460","first-page":"218","article-title":"Healthy planetary diet: do we have to rethink the recommendations based on the Mediterranean diet?","volume":"31","author":"P\u00e9rez-Mart\u00ednez","year":"2019","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1465","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11883-023-01109-y","article-title":"Eggs and Cardiovascular Disease Risk: An Update of Recent Evidence","volume":"25","author":"Carter","year":"2023","journal-title":"Curr Atheroscler Rep."},{"key":"10.1016\/j.arteri.2025.500889_bib1470","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.clnu.2021.03.003","article-title":"Egg consumption, overall diet quality, and risk of type 2 diabetes and coronary heart disease: A pooling project of US prospective cohorts","volume":"40","author":"Djouss\u00e9","year":"2021","journal-title":"Clin Nutr."},{"key":"10.1016\/j.arteri.2025.500889_bib1475","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/HCO.0000000000001048","article-title":"Artificial sweeteners and cardiovascular risk","volume":"38","author":"G\u00f3mez-Delgado","year":"2023","journal-title":"Curr Opin Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1480","first-page":"248","article-title":"Alimentos funcionales y nutrac\u00e9uticos en el tratamiento de la hipercolesterolemia: posicionamiento de la Sociedad Espa\u00f1ola de Arteriosclerosis 2023","volume":"35","author":"P\u00e9rez-Mart\u00ednez","year":"2023","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1485","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1490","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500889_bib1495","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1500","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1505","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500889_bib1510","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.004224","article-title":"Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis","volume":"11","author":"Kim","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"10.1016\/j.arteri.2025.500889_bib1515","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCULATIONAHA.116.025471","article-title":"Coronary Artery Calcium to Guide a Personalized Risk-Based Approach to Initiation and Intensification of Antihypertensive Therapy","volume":"135","author":"McEvoy","year":"2017","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1520","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.119.045010","article-title":"Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The MESA Study (Multi-Ethnic Study of Atherosclerosis)","volume":"141","author":"Cainzos-Achirica","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1525","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100427","article-title":"Contemporary use of coronary artery calcium for the allocation of aspirin in light of the 2022 USPSTF guideline recommendations","volume":"12","author":"Verghese","year":"2022","journal-title":"Am J Prev Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1530","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/clc.23918","article-title":"The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC","volume":"45","author":"Maniar","year":"2022","journal-title":"Clin Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1535","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for Asymptomatic Atherosclerosis Trialists. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"Fowkes","year":"2010","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2025.500889_bib1540","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejvs.2022.04.011","article-title":"Editor's Choice - European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease","volume":"65","author":"Naylor","year":"2023","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"10.1016\/j.arteri.2025.500889_bib1545","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ahj.2019.09.011","article-title":"The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics","volume":"218","author":"Nidorf","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.arteri.2025.500889_bib1550","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038656","article-title":"Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial","volume":"14","author":"Aggarwal","year":"2025","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.arteri.2025.500889_bib1555","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jacc.2019.08.012","article-title":"From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review","volume":"74","author":"Ahmadi","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1560","doi-asserted-by":"crossref","first-page":"n776","DOI":"10.1136\/bmj.n776","article-title":"Role of coronary artery calcium score in the primary prevention of cardiovascular disease","volume":"373","author":"Nasir","year":"2021","journal-title":"BMJ."},{"key":"10.1016\/j.arteri.2025.500889_bib1565","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jcmg.2020.10.016","article-title":"Coronary Artery Calcium to Improve the Efficiency of Randomized Controlled Trials in Primary Cardiovascular Prevention","volume":"14","author":"Cainzos-Achirica","year":"2021","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.arteri.2025.500889_bib1570","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2025.500889_bib1575","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA","volume":"379","author":"Johnston","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1580","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2025.500889_bib1585","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500889_bib1590","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","volume":"76","author":"Pan","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arteri.2025.500889_bib1595","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jacc.2019.03.013","article-title":"Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial","volume":"74","author":"Jukema","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1600","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehaa652","article-title":"Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial","volume":"41","author":"Budoff","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1605","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/heartjnl-2018-313108","article-title":"Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials","volume":"105","author":"Selak","year":"2019","journal-title":"Heart."},{"key":"10.1016\/j.arteri.2025.500889_bib1610","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMoa2208275","article-title":"Polypill Strategy in Secondary Cardiovascular Prevention","volume":"387","author":"Castellano","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1615","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1620","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaf174","article-title":"Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis","volume":"46","author":"Samuel","year":"2025","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1625","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"85","author":"Rao","year":"2025","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1630","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025551","article-title":"Network Meta-Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid-Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low-Density Lipoprotein Cholesterol","volume":"11","author":"Toth","year":"2022","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.arteri.2025.500889_bib1635","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"Pitavastatin to Prevent Cardiovascular Disease in HIV Infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1640","first-page":"128","article-title":"Indications of PCSK9 inhibitors in clinical practice. Recommendations of the Spanish Sociey of Arteriosclerosis (SEA), 2019","volume":"31","author":"Ascaso","year":"2019","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1645","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1056\/NEJMoa2210645","article-title":"Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk","volume":"387","author":"Das Pradhan","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract."},{"key":"10.1016\/j.arteri.2025.500889_bib1655","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2018.06.859","article-title":"Familial hypercholesterolemia treatments: Guidelines and new therapies","volume":"277","author":"Raal","year":"2018","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib1660","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib1665","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jacl.2018.09.006","article-title":"The spectrum of type III hyperlipoproteinemia","volume":"12","author":"Sniderman","year":"2018","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2025.500889_bib1670","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MED.0000000000000316","article-title":"Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder","volume":"24","author":"Koopal","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"10.1016\/j.arteri.2025.500889_bib1675","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/324647","article-title":"Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism","volume":"69","author":"Hegele","year":"2001","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.arteri.2025.500889_bib1680","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an \u201cFCS score\u201d","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib1685","first-page":"56","article-title":"Familial chylomicronemia and multifactorial chylomicronemia","volume":"33","author":"Mu\u00f1iz-Grijalvo","year":"2021","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1690","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jacl.2018.06.018","article-title":"New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia","volume":"12","author":"Serveaux Dancer","year":"2018","journal-title":"J Clin Lipidol."},{"key":"10.1016\/j.arteri.2025.500889_bib1695","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"Familial Lipoprotein Lipase Deficiency, Apo C-II Deficiency, and Hepatic Lipase Deficiency","author":"Brunzell","year":"2019"},{"key":"10.1016\/j.arteri.2025.500889_bib1700","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1194\/jlr.M002717","article-title":"Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia","volume":"51","author":"Olivecrona","year":"2010","journal-title":"J Lipid Res."},{"key":"10.1016\/j.arteri.2025.500889_bib1705","series-title":"GeneReviews\u00ae [Internet]","article-title":"Familial Lipoprotein Lipase Deficiency","author":"Burnett","year":"1999"},{"key":"10.1016\/j.arteri.2025.500889_bib1710","first-page":"193","article-title":"The concept of severe hypertriglyceridemia and its implications in clinical practice","volume":"30","author":"Pint\u00f3 Sala","year":"2018","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib1715","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ."},{"key":"10.1016\/j.arteri.2025.500889_bib1720","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOL.0b013e3283471972","article-title":"Genetic bases of hypertriglyceridemic phenotypes","volume":"22","author":"Johansen","year":"2011","journal-title":"Curr Opin Lipidol."},{"key":"10.1016\/j.arteri.2025.500889_bib1725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17512433.2017.1251839","article-title":"Building a better understanding of the burden of disease in familial chylomicronemia syndrome","volume":"10","author":"Ahmad","year":"2017","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.arteri.2025.500889_bib1730","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M088203","article-title":"Genetic and secondary causes of severe HDL deficiency and cardiovascular disease","volume":"59","author":"Geller","year":"2018","journal-title":"J Lipid Res."},{"key":"10.1016\/j.arteri.2025.500889_bib1735","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcad.2016.08.006","article-title":"Diagnosis and treatment of high density lipoprotein deficiency","volume":"59","author":"Schaefer","year":"2016","journal-title":"Prog Cardiovasc Dis."},{"key":"10.1016\/j.arteri.2025.500889_bib1740","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/17446651.2023.2204932","article-title":"Low cholesterol states: clinical implications and management","volume":"18","author":"Gill","year":"2023","journal-title":"Expert Rev Endocrinol Metab."},{"key":"10.1016\/j.arteri.2025.500889_bib1745","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(23)00733-X","article-title":"Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59\u00a0124 patients","volume":"401","author":"Staplin","year":"2023","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500889_bib1750","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"De la Sierra","year":"2011","journal-title":"Hypertension."},{"key":"10.1016\/j.arteri.2025.500889_bib1755","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","article-title":"Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data","volume":"384","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500889_bib1760","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500889_bib1765","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa2110730","article-title":"Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease","volume":"385","author":"Agarwal","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1770","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/STROKEAHA.119.028066","article-title":"First-Ever Ischemic Stroke and Incident Major Adverse Cardiovascular Events in 93 627 Older Women and Men","volume":"51","author":"Sposato","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2025.500889_bib1775","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke: A Randomized Clinical Trial and Meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arteri.2025.500889_bib1780","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1161\/STR.0000000000000418","volume":"54","author":"Amin","year":"2023","journal-title":"Stroke."},{"key":"10.1016\/j.arteri.2025.500889_bib1785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15226\/2374-6890\/2\/3\/00124","article-title":"Resistant Hypertension in Diabetes Mellitus","volume":"2","author":"Armario","year":"2015","journal-title":"J Endocrinol Diab."},{"key":"10.1016\/j.arteri.2025.500889_bib1790","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/HYPERTENSIONAHA.113.02026","article-title":"Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort","volume":"63","author":"Calhoun","year":"2014","journal-title":"Hypertension."},{"key":"10.1016\/j.arteri.2025.500889_bib1795","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007365","article-title":"Prevalence and Clinical Characteristics of Refractory Hypertension","volume":"6","author":"Armario","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.arteri.2025.500889_bib1800","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017634","article-title":"Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study","volume":"9","author":"Cardoso","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.arteri.2025.500889_bib1805","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc24-SINT","article-title":"Standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care."},{"key":"10.1016\/j.arteri.2025.500889_bib1810","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2337\/dc18-0836","article-title":"Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial","volume":"42","author":"Salas-Salvad\u00f3","year":"2019","journal-title":"Diabetes Care."},{"key":"10.1016\/j.arteri.2025.500889_bib1815","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1820","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med."},{"issue":"10193","key":"10.1016\/j.arteri.2025.500889_bib1825","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.arteri.2025.500889_bib1830","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1835","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1840","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1845","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.arteri.2025.500889_bib1850","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2213-8587(19)30180-9","article-title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial","volume":"7","author":"Mosenzon","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.arteri.2025.500889_bib1855","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1860","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4158\/CS-2020-0490","article-title":"Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary","volume":"26","author":"Handelsman","year":"2020","journal-title":"Endocr Pract."},{"key":"10.1016\/j.arteri.2025.500889_bib1865","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/DMSO.S165740","article-title":"COSMIC project: consensus on the objectives of the metabolic syndrome in clinic","volume":"11","author":"Pedro-Botet","year":"2018","journal-title":"Diabetes Metab Syndr Obes."},{"key":"10.1016\/j.arteri.2025.500889_bib1870","first-page":"130","article-title":"The SEEN comprehensive clinical survey of adult obesity: Executive summary","volume":"68","author":"Ballesteros Pomar","year":"2021","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)."},{"key":"10.1016\/j.arteri.2025.500889_bib1875","series-title":"Gu\u00eda Espa\u00f1ola GIRO: gu\u00eda espa\u00f1ola del manejo integral y multidisciplinar de la obesidad en personas adultas","author":"Lecube","year":"2025"},{"key":"10.1016\/j.arteri.2025.500889_bib1880","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1007\/s11695-019-04043-8","article-title":"A Spanish Society joint SECO and SEEDO approach to the Post-operative management of the patients undergoing surgery for obesity","volume":"29","author":"Vilallonga","year":"2019","journal-title":"Obes Surg."},{"key":"10.1016\/j.arteri.2025.500889_bib1885","unstructured":"World Health Organization. Tobacco. WHO, 2025 [consultado 19 Dic 2025]. Disponible en: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco"},{"key":"10.1016\/j.arteri.2025.500889_bib1890","unstructured":"Instituto Nacional de Estad\u00edstica. Ministerio de Sanidad. Encuesta Europea de Salud en Espa\u00f1a 2020. Estado de salud (estado de salud percibido, enfermedades cr\u00f3nicas, dependencia funcional) [consultado 19 Dic 2025]. Disponible en: https:\/\/www.ine.es\/ss\/Satellite?L=es_ES&c=INESeccion_C&cid=1259926692949&p=%5C&pagename=ProductosYServicios%2FPYSLayout&param1=PYSDetalle&param3=1259924822888"},{"key":"10.1016\/j.arteri.2025.500889_bib1895","series-title":"How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease","year":"2010"},{"key":"10.1016\/j.arteri.2025.500889_bib1900","article-title":"Prevalencia de tabaquismo y h\u00e1bitos de vida relacionados con la salud en funci\u00f3n del uso del tabaco tras la implantaci\u00f3n de la Ley 42\/2010: an\u00e1lisis de encuestas de salud en Espa\u00f1a 2009-2017","volume":"93","author":"Garc\u00eda-Mayor","year":"2019","journal-title":"Rev Esp Salud Publica."},{"key":"10.1016\/j.arteri.2025.500889_bib1905","doi-asserted-by":"crossref","DOI":"10.18332\/tid\/204750","article-title":"Tobacco imagery in prime-time television in Spain: A content analysis","volume":"23","author":"Peruga","year":"2025","journal-title":"Tob Induc Dis."},{"key":"10.1016\/j.arteri.2025.500889_bib1910","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011045","article-title":"Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers","volume":"6","author":"Chaiton","year":"2016","journal-title":"BMJ Open."},{"key":"10.1016\/j.arteri.2025.500889_bib1915","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00846549","article-title":"Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire","volume":"12","author":"Fagerstrom","year":"1989","journal-title":"J Behav Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1920","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1989.tb03059.x","article-title":"Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day","volume":"84","author":"Heatherton","year":"1989","journal-title":"Br J Addict."},{"key":"10.1016\/j.arteri.2025.500889_bib1925","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2022.0395","article-title":"Treatment of Tobacco Smoking: A Review","volume":"327","author":"Rigotti","year":"2022","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2025.500889_bib1930","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis","volume":"1","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.arteri.2025.500889_bib1935","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"2013","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.arteri.2025.500889_bib1940","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMcp2032393","article-title":"Tobacco Addiction","volume":"387","author":"Selby","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arteri.2025.500889_bib1945","first-page":"797","article-title":"Canadian Cardiovascular Society Clinical Practice Update on Contemporary Approaches to Smoking Cessation","volume":"41","author":"Mir","year":"2025","journal-title":"Can J Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib1950","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2025.500889_bib1955","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3390\/jcm14041388","article-title":"Smoking Cessation Strategies After Acute Coronary Syndrome","volume":"14","author":"Nazir","year":"2025","journal-title":"J Clin Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1960","doi-asserted-by":"crossref","first-page":"105700","DOI":"10.1016\/j.phrs.2021.105700","article-title":"Cytisine and cytisine derivatives. More than smoking cessation aids","volume":"170","author":"Gotti","year":"2021","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.arteri.2025.500889_bib1965","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"5","author":"Livingstone-Banks","year":"2023","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.arteri.2025.500889_bib1970","article-title":"Electronic cigarettes for smoking cessation","author":"Lindson","year":"2025","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.arteri.2025.500889_bib1975","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.121.054967","article-title":"Combined Associations of Changes in Noncombustible Nicotine or Tobacco Product and Combustible Cigarette Use Habits With Subsequent Short-Term Cardiovascular Disease Risk Among South Korean Men: A Nationwide Cohort Study","volume":"144","author":"Choi","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1980","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.amepre.2020.11.011","article-title":"Heated Tobacco Products: Awareness and Ever Use Among U.S. Adults","volume":"60","author":"Azagba","year":"2021","journal-title":"Am J Prev Med."},{"key":"10.1016\/j.arteri.2025.500889_bib1985","unstructured":"U.S. Food and Drug Administration (FDA). FDA Authorizes Marketing of IQOS Tobacco Heating System with \u2018Reduced Exposure\u2019 Information. FDA, 2022 [consultado 19 Dic 2025]. Disponible en: https:\/\/extranet.who.int\/fctcapps\/sites\/default\/files\/resourcedbdoc\/FDA%20Authorizes%20marketing%20of%20IQOS%20Tobacco%20Heating%20System%20with%20Reduced%20Exposure%20Information.pdf"},{"key":"10.1016\/j.arteri.2025.500889_bib1990","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib1995","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.114.008201","article-title":"Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning","volume":"129","author":"Patel","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib2000","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA."},{"key":"10.1016\/j.arteri.2025.500889_bib2005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib2010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s10840-022-01383-x","article-title":"Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control","volume":"66","author":"Gomez","year":"2023","journal-title":"J Interv Card Electrophysiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10654-022-00914-0","article-title":"Blood pressure, hypertension and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","volume":"38","author":"Aune","year":"2023","journal-title":"Eur J Epidemiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2020","article-title":"Glycemic variability and the risk of atrial fibrillation: a meta-analysis","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.arteri.2025.500889_bib2025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.arteri.2025.500889_bib2030","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/ejhf.2884","article-title":"Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study","volume":"25","author":"Pascual-Figal","year":"2023","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.arteri.2025.500889_bib2035","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12872-021-01858-1","article-title":"Meta-analysis of metabolic syndrome and its individual components with risk of atrial fibrillation in different populations","volume":"21","author":"Zheng","year":"2021","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.arteri.2025.500889_bib2050","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.hlc.2023.02.009","article-title":"Prevalence and Prognostic Implication of Atrial Fibrillation in Heart Failure Subtypes: Systematic Review and Meta-Analysis","volume":"32","author":"Mundisugih","year":"2023","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.arteri.2025.500889_bib2055","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3390\/cells12121661","article-title":"Mechanisms of Atrial Fibrillation in Obstructive Sleep Apnoea","volume":"12","author":"Saleeb-Mousa","year":"2023","journal-title":"Cells."},{"key":"10.1016\/j.arteri.2025.500889_bib2060","article-title":"Association between obstructive sleep apnea (OSA) and atrial fibrillation (AF): A dose-response meta-analysis","volume":"101","author":"Zhang","year":"2022","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.arteri.2025.500889_bib2065","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.arteri.2025.500889_bib2070","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.CIR.82.4.1106","article-title":"Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials","volume":"82","author":"Coplen","year":"1990","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib2075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.hrthm.2017.01.038","article-title":"Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation","volume":"14","author":"Padfield","year":"2017","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.arteri.2025.500889_bib2080","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib2085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ahj.2018.09.002","article-title":"Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study","volume":"207","author":"Turakhia","year":"2019","journal-title":"Am Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib2090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2019.08.019","article-title":"MAFA II Investigators. Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation","volume":"74","author":"Guo","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol Abstinence in Drinkers with Atrial Fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib2100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacep.2022.12.002","article-title":"An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial","volume":"9","author":"Elliott","year":"2023","journal-title":"JACC Clin Electrophysiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2105","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early Rhythm-Control Therapy in Patients with Atrial Fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib2110","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib2115","doi-asserted-by":"crossref","first-page":"h4451","DOI":"10.1136\/bmj.h4451","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ."},{"key":"10.1016\/j.arteri.2025.500889_bib2120","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1056\/NEJMoa041233","article-title":"Outpatient treatment of recent-onset atrial fibrillation with the \u201cpill-in-the-pocket\u201d approach","volume":"351","author":"Alboni","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.arteri.2025.500889_bib2125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0002-9149(00)01128-0","article-title":"Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm","volume":"86","author":"Mart\u00ednez-Marcos","year":"2000","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology Guidelines for Diagnosis and Management of Atrial Fibrillation: A Viewpoint from a Practicing Clinician's Perspective","volume":"124","author":"Potpara","year":"2024","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.arteri.2025.500889_bib2135","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/jcm9061698","article-title":"Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry","volume":"9","author":"Krittayaphong","year":"2020","journal-title":"J Clin Med."},{"key":"10.1016\/j.arteri.2025.500889_bib2140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation."},{"issue":"FI1","key":"10.1016\/j.arteri.2025.500889_bib2145","doi-asserted-by":"crossref","first-page":"f11","DOI":"10.1093\/ehjcvp\/pvab002","article-title":"Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients","volume":"7","author":"Menichelli","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother."},{"key":"10.1016\/j.arteri.2025.500889_bib2150","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation."},{"key":"10.1016\/j.arteri.2025.500889_bib2155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.medcli.2023.09.003","article-title":"Factor XI inhibitors: A new era in antithrombotic therapy","volume":"162","author":"P\u00e1ramo","year":"2024","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.arteri.2025.500889_bib2160","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study","volume":"28","author":"Ray","year":"2021","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2165","doi-asserted-by":"crossref","first-page":"100624","DOI":"10.1016\/j.lanepe.2023.100624","article-title":"Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study","volume":"29","author":"Ray","year":"2023","journal-title":"Lancet Reg Health Eur."},{"key":"10.1016\/j.arteri.2025.500889_bib2170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2023.04.013","article-title":"Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain","volume":"375","author":"Cos\u00edn-Sales","year":"2023","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.arteri.2025.500889_bib2175","first-page":"219","article-title":"Hypercholesterolaemia control in Spain: The same situation with different regional realities","volume":"35","author":"Pedro-Botet","year":"2023","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib2180","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2185","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/2047487320908698","article-title":"Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries","volume":"28","author":"Kotseva","year":"2021","journal-title":"Eur J Prev Cardiol."},{"key":"10.1016\/j.arteri.2025.500889_bib2190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.01.014","article-title":"Therapeutic interventions and success in risk factor control for secondary prevention of stroke","volume":"18","author":"\u00c1lvarez-Sabin","year":"2009","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"10.1016\/j.arteri.2025.500889_bib2195","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.medcli.2010.04.035","article-title":"Control de los factores de riesgo cardiovascular en pacientes con ictus atendidos en Atenci\u00f3n Primaria en Espa\u00f1a. Estudio ICTUSCARE. [Control of cardiovascular risk factors in patients with stroke attended in primary care in Spain. ICTUSCARE study]","volume":"136","author":"Abell\u00e1n Alem\u00e1n","year":"2011","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.arteri.2025.500889_bib2200","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J."},{"key":"10.1016\/j.arteri.2025.500889_bib2205","first-page":"1","article-title":"Causes of failure to achieve the low density lipoprotein cholesterol therapeutic target in patients with high and very high vascular risk controlled in Lipid and Vascular Risk Units. EROMOT study","volume":"30","author":"Morales","year":"2018","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib2210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12889-018-5269-0","article-title":"Socioeconomic inequalities in cardiometabolic control in patients with type 2 diabetes","volume":"18","author":"Ib\u00e1\u00f1ez","year":"2018","journal-title":"BMC Public Health."},{"key":"10.1016\/j.arteri.2025.500889_bib2215","first-page":"257","article-title":"Mapa de recursos y necesidades asistenciales del paciente dislipid\u00e9mico en Espa\u00f1a: estudio MADI. [Map of resources and healthcare needs for patients with dyslipidaemia in Spain: The MADI study]","volume":"28","author":"Pedro-Botet","year":"2016","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib2220","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.hipert.2016.10.004","article-title":"\u00c1rea de Atenci\u00f3n Integrada de Riesgo Vascular: un nuevo modelo organizativo para el control global de los factores de riesgo. [Integrated Management Area of Vascular Risk: A new organisational model for global control of risk factors]","volume":"34","author":"Armario","year":"2017","journal-title":"Hipertens Riesgo Vasc."},{"issue":"Suppl 2","key":"10.1016\/j.arteri.2025.500889_bib2225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0025-7753(09)71752-X","article-title":"Abordaje multidisciplinar de la enfermedad aterotromb\u00f3tica. [Multidisciplinary approach to atherothrombotic disease]","volume":"132","author":"Su\u00e1rez","year":"2009","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.arteri.2025.500889_bib2230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.hipert.2009.05.001","article-title":"Aplicaci\u00f3n pr\u00e1ctica de los indicadores de calidad asistencial en el paciente hipertenso","volume":"26","author":"Benach","year":"2009","journal-title":"Hipertens Riesgo Vasc."},{"key":"10.1016\/j.arteri.2025.500889_bib2235","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/HJH.0000000000001634","article-title":"A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation\/European Society of Hypertension\/International Organization for Standardization (AAMI\/ESH\/ISO) Collaboration Statement","volume":"36","author":"Stergiou","year":"2018","journal-title":"J Hypertens."},{"key":"10.1016\/j.arteri.2025.500889_bib2240","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.recesp.2020.05.032","article-title":"Gesti\u00f3n cl\u00ednica en el \u00e1rea cardiovascular. Medir para mejorar. [Clinical management in cardiology. Measurement as a means to improvement]","volume":"74","author":"Gonz\u00e1lez-Juanatey","year":"2021","journal-title":"Rev Esp Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2025.500889_bib2245","first-page":"65","article-title":"Relationship beetween Primary and Hospital Care in cardiovascular prevention and treatment of dyslipidemias. Derivation algorithm. Discharge criteria","volume":"33","author":"S\u00e1nchez Chaparro M\u00c1","year":"2021","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib2250","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.hipert.2021.03.003","article-title":"2021 Spanish Society of Hypertension position statement about telemedicine","volume":"38","author":"Gij\u00f3n-Conde","year":"2021","journal-title":"Hipertens Riesgo Vasc."},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2025.500889_bib2255","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.2337\/dc23-S008","article-title":"8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care."},{"issue":"Suppl 1","key":"10.1016\/j.arteri.2025.500889_bib2260","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2337\/dc23-S009","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care."},{"key":"10.1016\/j.arteri.2025.500889_bib2265","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.hipert.2022.09.002","volume":"39","author":"Gorostidi","year":"2022","journal-title":"Hipertens Riesgo Vasc."},{"key":"10.1016\/j.arteri.2025.500889_bib2270","first-page":"26","article-title":"Criteria for referring patients to Spanish Atherosclerosis Society lipid units","volume":"31","author":"S\u00e1nchez-Chaparro M.\u00c1.","year":"2019","journal-title":"Clin Investig Arterioscler."},{"key":"10.1016\/j.arteri.2025.500889_bib2275","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","article-title":"Secondary arterial hypertension: when, who, and how to screen?","volume":"35","author":"Rimoldi","year":"2014","journal-title":"Eur Heart J."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916825001329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916825001329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:06:54Z","timestamp":1777579614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916825001329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":256,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0214916825001329"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2025.500889","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Est\u00e1ndares SEA 2026 para el control global del riesgo vascular","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2025.500889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Arteriosclerosis.","name":"copyright","label":"Copyright"}],"article-number":"500889"}}